NASDAQ:ISRG • US46120E6023
The current stock price of ISRG is 493.35 USD. In the past month the price decreased by -7.79%. In the past year, price decreased by -16.63%.
ChartMill assigns a fundamental rating of 7 / 10 to ISRG. ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months ISRG reported a non-GAAP Earnings per Share(EPS) of 8.93. The EPS increased by 21.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.38% | ||
| ROA | 13.96% | ||
| ROE | 16.02% | ||
| Debt/Equity | 0 |
42 analysts have analysed ISRG and the average price target is 625.53 USD. This implies a price increase of 26.79% is expected in the next year compared to the current price of 493.35.
For the next year, analysts expect an EPS growth of 14.46% and a revenue growth 15.92% for ISRG
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.55 | 195.936B | ||
| SYK | STRYKER CORP | 24.42 | 139.985B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 110.826B | ||
| IDXX | IDEXX LABORATORIES INC | 42.26 | 50.254B | ||
| BDX | BECTON DICKINSON AND CO | 11.26 | 50.113B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.39 | 44.027B | ||
| RMD | RESMED INC | 20.83 | 36.792B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.25 | 36.615B | ||
| DXCM | DEXCOM INC | 27.89 | 27.309B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA 94086 US
CEO: Gary S. Guthart
Employees: 15638
Phone: 13026587581
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
The current stock price of ISRG is 493.35 USD. The price increased by 1.55% in the last trading session.
ISRG does not pay a dividend.
ISRG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
ISRG stock is listed on the Nasdaq exchange.
INTUITIVE SURGICAL INC (ISRG) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
INTUITIVE SURGICAL INC (ISRG) has a market capitalization of 175.20B USD. This makes ISRG a Large Cap stock.